Patents-Review.com
ClassID:

96986 ⎘

C07K14/57545 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Hormones Neuropeptide Y

Recent Application in this class:
#1
20250230213
2025-07-17

PROTEIN TYROSINE-TYROSINE ANALOGS AND METHODS OF USING THE SAME

 #2
20250026803
2025-01-23

IMMUNOGLOBULINS AND USES THEREOF

 #3
20240209055
2024-06-27

Protein tyrosine-tyrosine analogs and methods of using the same

 #4
20240166709
2024-05-23

ANALOGUES OF PYY

 #5
20240117000
2024-04-11

GLUCAGON LIKE PEPTIDE 1 (GLP-1) FUSION PEPTIDE COUPLED CYCLIC PEPTIDE TYROSINE TYROSINE CONJUGATES AND USES THEREOF

 #6
20240018208
2024-01-18

CYCLIC PEPTIDE TYROSINE TYROSINE COMPOUNDS AS MODULATORS OF NEUROPEPTIDE Y RECEPTORS

 #7
20230365644
2023-11-16

ANTIBODY-COUPLED CYCLIC PEPTIDE TYROSINE TYROSINE COMPOUNDS AS MODULATORS OF NEUROPEPTIDE Y RECEPTORS

 #8
20230332135
2023-10-19

MIRAC PROTEINS

 #9
20230322886
2023-10-12

RECOMBINANT PROTEIN COMPRISING MULTIPLE MULTI-PEPTIDE SETS, PHARMACEUTICAL COMPOSITION COMPRISING THE RECOMBINANT PROTEIN, AND METHOD FOR PREPARING THE RECOMBINANT PROTEIN

 #10
20230322872
2023-10-12

RECOMBINANT PROTEIN COMPRISING MULTIPLE MULTI-PEPTIDE SETS, PHARMACEUTICAL COMPOSITION COMPRISING THE RECOMBINANT PROTEIN, AND METHOD FOR PREPARING THE RECOMBINANT PROTEIN

 #11
20230272011
2023-08-31

SERUM ALBUMIN-BINDING POLYPEPTIDES

 #12
20230126347
2023-04-27

Analogues of PYY

 #13
20220380430
2022-12-01

Non-Transgenic Functional Rescue of Neuropeptides

 #14
20220241377
2022-08-04

RECEPTOR-TARGETING PEPTIDE-DRUG CONJUGATES

 #15
20220025009
2022-01-27

Protein tyrosine-tyrosine analogs and methods of using the same

 #16
20210332335
2021-10-28

In vivo protein N-acylation

 #17
20210253661
2021-08-19

Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof

 #18
20210206822
2021-07-08

Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

 #19
20210163566
2021-06-03

Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

 #20
20210094998
2021-04-01

Immunoglobulins and uses thereof

 #21
20200385439
2020-12-10

Immunoglobulins and uses thereof

 #22
20200308245
2020-10-01

Analogues of PYY

 #23
20200283491
2020-09-10

Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

 #24
20200172592
2020-06-04

Neuropeptide Y fragment capable of releasing hematopoietic stem cells into blood and treating osteoporosis

 #25
20200140514
2020-05-07

Protein tyrosine-tyrosine analogs and methods of using the same

 #26
20200063111
2020-02-27

In vivo protein N-acylation

 #27
20190367577
2019-12-05

Immunoglobulins and uses thereof

 #28
20190345214
2019-11-14

Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

 #29
20190298849
2019-10-03

Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

 #30
20190263879
2019-08-29

Immunoglobulins and uses thereof

 #31
20190211072
2019-07-11

TRI-AGONIST FOR THE GLu, GLP-1 AND NPY2 RECEPTORS

 #32
20190169256
2019-06-06

Antagonists of fish reproduction

 #33
20190024116
2019-01-24

Vector

 #34
20190002517
2019-01-03

NEUROPEPTIDE Y-DERIVED PEPTIDES

 #35
20180340012
2018-11-29

METHODS AND COMPOSITIONS RELATED TO IMPROVING PROPERTIES OF PHARMACOLOGICAL AGENTS TARGETING NERVOUS SYSTEM

 #36
20180127476
2018-05-10

Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

 #37
20180117170
2018-05-03

Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

 #38
20170369867
2017-12-28

Mirac proteins

 #39
20170044522
2017-02-16

Mirac proteins

 #40
20170020951
2017-01-26

Neuropeptide analogs, compositions, and methods for treating pain

 #41
20160361429
2016-12-15

Regulation of specific spinal neurons regulating pain transmission via chimeric toxins

 #42
20160060320
2016-03-03

Neuropeptide Y-derived peptides

 #43
20150238626
2015-08-27

RECEPTOR LIGAND LINKED CYTOTOXIC MOLECULES

 #44
20150203554
2015-07-23

Methods and compositions related to improving properties of pharmacological agents targeting nervous system

 #45
20140378660
2014-12-25

Mirac proteins

 #46
20140356344
2014-12-04

Mirac proteins

 #47
20140329742
2014-11-06

Peptide YY analogs

 #48
20140274887
2014-09-18

Compounds for control of appetite

 #49
20140255376
2014-09-11

Regulation of specific spinal neurons regulating pain transmission via chimeric toxins

 #50
20140187748
2014-07-03

Mirac proteins

 #51
20130324467
2013-12-05

NEUROPEPTIDE ANALOGS, COMPOSITIONS, AND METHODS FOR TREATING PAIN

 #52
20130244947
2013-09-19

Methods and compositions related to improving properties of pharmacological agents targeting nervous system

 #53
20130034572
2013-02-07

Compositions and methods for brain delivery of analgesic peptides

 #54
20130023464
2013-01-24

Peptide tyrosine tyrosine analogues

 #55
20120259092
2012-10-11

NPY ANTAGONISTS

 #56
20120258865
2012-10-11

Mirac proteins

 #57
20120164127
2012-06-28

Mirac proteins

 #58
20120130044
2012-05-24

Stable analogs of peptide and polypeptide therapeutics

 #59
20120040899
2012-02-16

Method for treating hyperglycemia

 #60
20120040885
2012-02-16

Analogues of neuropeptide Y having at least one synthetic amino acid substitution

 #61
20110313132
2011-12-22

PROCESS FOR THE PRODUCTION OF PREFORMED CONJUGATES OF ALBUMIN AND A THERAPEUTIC AGENT

 #62
20110312878
2011-12-22

PHARMACOLOGICALLY ACTIVE PEPTIDE CONJUGATES HAVING A REDUCED TENDENCY TOWARDS ENZYMATIC HYDROLYSIS

 #63
20110305711
2011-12-15

CGRP antibodies

 #64
20110172147
2011-07-14

NEUROPEPTIDE-2 RECEPTOR (Y-2R) AGONISTS

 #65
20100331245
2010-12-30

PEPTIDE YY ANALOGS

 #66
20100260739
2010-10-14

Mirac Proteins

 #67
20100168215
2010-07-01

METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROLOGICAL DISEASE

 #68
20100137223
2010-06-03

Neuropeptide-2 receptor (Y-2R) agonists and uses thereof

 #69
20100069307
2010-03-18

Neuropeptide-2 receptor (Y-2R) agonists

 #70
20090281031
2009-11-12

Methods and compositions related to improving properties of pharmacological agents targeting nervous system

 #71
20090233840
2009-09-17

Modified Dynorphin Expression in Animals and Identification of Compounds for Treatment of Obesity and Diabetes

 #72
20090227519
2009-09-10

Compounds for control of appetite

 #73
20090192092
2009-07-30

Neuropeptides and their use for pest control

 #74
20090105122
2009-04-23

Selective neuropeptide y2 receptor agonists

 #75
20090029406
2009-01-29

Npy Y4 Agonist as Therapeutic Agent for Disease Accompanied by Intestinal Tract Dysfunction

 #76
20080292548
2008-11-27

Compounds and methods for F labeled agents

 #77
20080255046
2008-10-16

Y2 selective receptor agonists for therapeutic interventions

 #78
20080234467
2008-09-25

Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis

 #79
20080227954
2008-09-18

Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis

 #80
20080194486
2008-08-14

Anti-obesity agents

 #81
20080139785
2008-06-12

Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis

 #82
20080051557
2008-02-28

Stable analogs of peptide and polypeptide therapeutics

 #83
20080015152
2008-01-17

Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis

 #84
20070293418
2007-12-20

Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis

 #85
20070269863
2007-11-22

Process for the production of preformed conjugates of albumin and a therapeutic agent

 #86
20070197445
2007-08-23

Compounds for control of appetite

 #87
20070135351
2007-06-14

Neuropeptide-2 receptor (Y-2R) agonists and uses thereof

 #88
20060211610
2006-09-21

Peptide YY analogs

 #89
20060160742
2006-07-20

Neuropeptide-2 receptor (Y-2R) agonists and uses thereof

 #90
20060105942
2006-05-18

Inhibition of cell division based use of analogs of neuropeptide y

 #91
20060063699
2006-03-23

Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis

 #92
20060052301
2006-03-09

Splice variants of peptide YY, neuropeptide Y, pancreatic peptide Y and Amylin, and uses thereof

 #93
20050233972
2005-10-20

Neuropeptides and their use for pest control

 #94
20050176643
2005-08-11

Anti-obesity agents

 #95
20050136036
2005-06-23

Methods and compositions for the treatment of neurological disease

 #96
20050107327
2005-05-19

Method for reducing overproduction of neuropeptide Y in an individual

 #97
20050059605
2005-03-17

Chemically modified metabolites of regulatory peptides and methods of producing and using same

 #98
20050049177
2005-03-03

Stable analogs of peptide and polypeptide therapeutics